2024 Expert Speaker Faculty

Anna-Maria Georgoudaki

Sr R&D manager

Glycostem Therapeutics

Antoine Sreih

Vice President of Clinical Development

Cullinan Therapeutics

David Porter Director, Cell Therapy and Transplant Penn Medicine/ University of Pennsylvania

David Porter

Director - Cell Therapy & Transplant

Penn Medicine/ University of Pennsylvania

Fred Aslan - President & Chief Executive Officer, Artiva Biotherapeutics, Inc

Fred Aslan

Chief Executive Officer

Artiva Biotherapeutics, Inc

Greg Deener -Chief Executive Officer, iCell Gene Therapeutics

Greg Deener

Chief Executive Officer

iCell Gene Therapeutics

Haig Aghajanian - Co-Founder, Vice President & Head of Research, Capstan Therapeutics

Haig Aghajanian

Co-Founder, Vice President & Head of Research

Capstan Therapeutics

Isin dalkilic - Sr. Director, Orna Therapeutics

Isin dalkilic

Senior Director & Head of Drug Discovery

Orna Therapeutics

Jason Damiano - Chief Scientific Officer, Appia Bio

Jason Damiano

Chief Scientific Officer

Appia Bio

Jennifer Bush - Chief Operating Officer, Artiva Biotherapeutics, Inc

Jennifer Bush

Chief Operating Officer

Artiva Biotherapeutics, Inc

Laurence Morel - Professor and Chair, UT Health San Antonio

Laurence morel

Professor

UT Health San Antonio

Marc Martinez Llordella - Co-founder & Vice President - Biology, Quell Therapeutics

Marc Martinez Llordella

Co-founder & Vice President - Biology

Quell Therapeutics

Marko Radic, Ph.D. Associate Professor, The University of Tennessee Health Science Center

Marko Radic

Associate Professor

The University of Tennessee Health Science Center

Marlene Carrasco - Global Clinical Head Immunology Cell Therapy, AstraZeneca

Marlene Carrasco

Global Clinical Head Immunology Cell Therapy

AstraZeneca

Matthew Collinson-Pautz - Director - Preclinical & Translational Research, Indapta Therapeutics

Matthew Collinson-Pautz

Director, Preclinical and Translational Research

Indapta Therapeutics

Maximilian Konig - Director Cellular Therapy Program Autoimmunity, John Hopkins University School of Medicine

Maximilian Konig

Director Cellular Therapy Program Autoimmunity

John Hopkins University School of Medicine

Metin Kurtoglu - CTO, Cartesian Therapeutics

Metin Kurtoglu

Chief Medical Officer, Chief Good Manufacturing Practices & Technology Officer

Cartesian Therapeutics

Mike Dybbs - Partner, Samsara BioCapital

Mike Dybbs

Partner

Samsara BioCapital

Milos Miljkovic

Chief Medical Officer

Cartesian Therapeutics

Musheng Bao

Vice President & Head of Biology

Nona Biosciences

Paolo Casali - University of Texas Ashbel Smith Distinguished Professor, UT Health San Antonio

Paolo Casali

UT Ashbel Smith Professor

UT Health San Antonio

Rachel Hourigan - Research Analyst Lead, Beacon

Rachel Hourigan

Research Analyst Lead

Beacon

Rahul Patel - Independent Subject Matter Expert

Rahul Patel

Independent Subject Matter Expert

/

Renee Randazzo

Vice President Global Program Lead Cell Therapy Organization

Bristol Myers Squibb

Richard Ransohoff - Venture Partner, Third Rock Ventures LLC

Richard Ransohoff

Venture Partner

Third Rock Ventures LLC

Samik Basu - Chief Scientific Officer, Cabaletta Bio

Samik Basu

Chief Scientific Officer

Cabaletta Bio

Stefanie Koristka - Principal Scientist, Intellia Therapeutics

Stefanie Koristka

Principal Scientist

Intellia Therapeutics

Stefanie Mandl - Chief Scientific Officer, Indapta Therapeutics

Stefanie Mandl

Chief Scientific Officer

Indapta Therapeutics

Stephen Waggoner - Professor, Cincinatti Children’s Medical Center

Stephen Waggoner

Professor

Cincinatti Children’s Medical Center

Susanne Diehl - Global Program Head Immunology, Novartis

Susanne Diehl

Global Program Head Immunology

Novartis

Timothy Campbell - Founder & VP of Biology, Bristol Myers Squibb

Timothy Campbell

Chimeric Antigen Receptor -T Manufacturing , Training & Compliance Manager

Bristol Myers Squibb

Tom Wickham - Chief Scientific Officer, GentiBio

Tom Wickham

Chief Scientific Officer

GentiBio

Tony Arulanandam - CEO and Founder, Synaptimmune Therapeutics

Tony Arulanandam

Chief Executive Officer and Founder

Synaptimmune Therapeutics

Vaneet Sandhu

Vice President Clinical Development, Autoimmunity

Fate Therapeutics

Yongke Zhang - SCO, IASO BioTherapeutics

Yongke zhang

Chief Scientific Officer

IASO BioTherapeutics

2024 EVENT GUIDE

REGISTER INTEREST